Is dengue curable in Philippines?

Is dengue curable in Philippines?

Dengue is a mosquito-borne disease that has affected many in the Philippines over the years. In fact, there were nearly 80,000 cases from January to late November last year. While there is no cure for dengue, one of the best ways to prevent the worsening of the disease is through early detection.

How to avoid dengue fever?

Use insect repellent, wear long-sleeved shirts and long pants, and control mosquitoes inside and outside your home. Each year, an estimated 400 million people are infected with dengue virus through the bites of infected mosquitoes.

Which day is critical in dengue?

The critical phase of dengue begins at defervescence and typically lasts 24–48 hours. Most patients clinically improve during this phase, but those with substantial plasma leakage can, within a few hours, develop severe dengue as a result of a marked increase in vascular permeability.

Who is most affected by dengue in the Philippines?

A recent review of the epidemiology of dengue in the Philippines showed that the incidence rate of dengue was highest among children of 5–14 years of age, with over 80% of dengue-related deaths occurring among individuals of less than 20 years of age.

Is sunlight good for dengue patient?

By Kate Bandoo, Publishing Assistant. Researchers in Brazil have created floating blocks that could be added to stagnant water to suppress the transmission of dengue fever.

Which fruit is good for dengue?

Papaya. For those who are suffering from dengue, Papaya leaves are the best option to go for. Just crush the papaya leaves and squeeze them to extract the juice. Its extract increases platelets counts to a great extent.

Is Dengvaxia approved by DOH?

The Department of Health (DOH), in a decision dated 19 August 2019, has upheld the Food and Drug Administration’s (FDA) permanent revocation of the Certificates of Produce Registration (CPRs) of dengue vaccine Dengvaxia due to the continued failure of manufacturer Sanofi Pasteur, Inc. to submit post-approval …

  • August 22, 2022